Covered recipient · General Payments record
TAZIALYNN LEILANI LYNAM
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$3,855.31
- Reported across 159 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $646.99 | 28 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $165.45 | 7 |
| Novo Nordisk AS | $94.87 | 5 |
| DEXCOM, INC. | $85.06 | 4 |
| ABBVIE INC. | $81.78 | 3 |
| Indivior Inc. | $50.90 | 2 |
| Amgen Inc. | $49.45 | 2 |
| Exact Sciences Corporation | $31.15 | 1 |
| PFIZER INC. | $26.32 | 1 |
| Gilead Sciences, Inc. | $25.10 | 1 |
| EMD Serono, Inc. | $23.84 | 1 |
| GlaxoSmithKline, LLC. | $13.07 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (28)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $24.59 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107568868 | CMS |
| ABBVIE INC. | $32.63 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107568870 | CMS |
| ABBVIE INC. | $24.56 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107568872 | CMS |
| Amgen Inc. | $22.41 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117615900 | CMS |
| Amgen Inc. | $27.04 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117315568 | CMS |
| Dexcom, Inc. | $24.01 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153389332 | CMS |
| Dexcom, Inc. | $23.41 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153389334 | CMS |
| Dexcom, Inc. | $22.59 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153389336 | CMS |
| Dexcom, Inc. | $15.05 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153389338 | CMS |
| EMD Serono, Inc. | $23.84 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120253193 | CMS |
| Exact Sciences Corporation | $31.15 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114506747 | CMS |
| Gilead Sciences, Inc. | $25.10 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133699533 | CMS |
| GlaxoSmithKline, LLC. | $13.07 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116644640 | CMS |
| Indivior Inc. | $17.55 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144561155 | CMS |
| Indivior Inc. | $33.35 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144561157 | CMS |
| Lilly USA, LLC | $27.10 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135968386 | CMS |
| Lilly USA, LLC | $26.74 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135978984 | CMS |
| Lilly USA, LLC | $25.52 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135963860 | CMS |
| Lilly USA, LLC | $21.48 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135871634 | CMS |
| Lilly USA, LLC | $17.89 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135923338 | CMS |
| Lilly USA, LLC | $22.55 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135963862 | CMS |
| Lilly USA, LLC | $24.17 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135871630 | CMS |
| Novo Nordisk Inc | $19.68 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100326886 | CMS |
| Novo Nordisk Inc | $15.42 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100643401 | CMS |
| Novo Nordisk Inc | $20.01 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100255864 | CMS |
| Novo Nordisk Inc | $21.11 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100636173 | CMS |
| Novo Nordisk Inc | $18.65 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100354056 | CMS |
| PFIZER INC. | $26.32 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131633179 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.